TCBWMS
ACTU

Texas Capital Bank Wealth Management Services’s Actuate Therapeutics ACTU Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$259K Hold
94,592
– – 0.02% 302
2025
Q4 		$579K Buy
+94,592
New +$650K 0.03% 184

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Texas Capital Bank Wealth Management Services's ACTU Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services held its Actuate Therapeutics (ACTU) position steady in Q1 2026 at 94,592 shares worth $259K. The position accounts for 0.02% of the portfolio, ranked #302.

Texas Capital Bank Wealth Management Services first reported a position in ACTU in Q4 2025 and has held it in 2 quarters since. The position peaked at $579K in Q4 2025. 61 funds tracked by Wall St. Rank hold ACTU as of Q1 2026.

  • Texas Capital Bank Wealth Management Services held 94,592 shares of Actuate Therapeutics worth $259K as of Q1 2026.
  • Texas Capital Bank Wealth Management Services left its Actuate Therapeutics share count unchanged in Q1 2026.
  • Actuate Therapeutics made up 0.02% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #302 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Actuate Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Texas Capital Bank Wealth Management Services's Actuate Therapeutics position peaked at $579K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.